Giorgia Rizza
Overview
Explore the profile of Giorgia Rizza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finessi M, Cioffi M, Grimaldi S, Fronda M, Rovera G, Passera R, et al.
Radiol Med
. 2024 Dec;
130(2):271-279.
PMID: 39681817
Purpose: We aimed to evaluate the prognostic impact of baseline clinical features and treatment procedure, including liver function measured with albumin-bilirubin (ALBI) formula and dosing methods in HCC patients treated...
2.
Rizza G, Glynou K, Eletskaya M
World J Transplant
. 2024 Sep;
14(3):90949.
PMID: 39295979
Background: Hepatitis B immunoglobulin (HBIG) in combination with a potent nucleos(t)ide analog is considered the standard of care for prophylaxis against hepatitis B virus (HBV) reinfection after liver transplantation for...
3.
De Stefano N, Patrono D, Colli F, Rizza G, Paraluppi G, Romagnoli R
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001436
Hepatocellular carcinoma (HCC) remains the leading oncological indication for liver transplantation (LT), with evolving and broadened inclusion criteria. Immune checkpoint inhibitors (ICIs) gained a central role in systemic HCC treatment...
4.
Steinberg I, Patrono D, De Cesaris E, Luca M, Catalano G, Marro M, et al.
Artif Organs
. 2023 Aug;
47(10):1592-1603.
PMID: 37548353
Background: Abdominal normothermic regional perfusion (A-NRP) allows in-situ reperfusion and recovery of abdominal organs metabolism in donors after circulatory death (DCD). Besides improving liver transplantation outcomes, liver injury and function...
5.
Patrono D, De Stefano N, Vissio E, Apostu A, Petronio N, Vitelli G, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373676
Liver allograft steatosis is a significant risk factor for postoperative graft dysfunction and has been associated with inferior patient and graft survival, particularly in the case of moderate or severe...
6.
Patrono D, Colli F, Colangelo M, De Stefano N, Apostu A, Mazza E, et al.
J Clin Med
. 2023 Mar;
12(5).
PMID: 36902813
Perihilar cholangiocarcinomas (pCCA) are rare yet aggressive tumors originating from the bile ducts. While surgery remains the mainstay of treatment, only a minority of patients are amenable to curative resection,...
7.
Patrono D, Zanierato M, Vergano M, Magaton C, Diale E, Rizza G, et al.
Transpl Int
. 2022 May;
35:10390.
PMID: 35529593
Prolonged warm ischemia time (WIT) has a negative prognostic value in liver transplantation (LT) using grafts procured after circulatory death (DCD). To assess the value of abdominal normothermic regional perfusion...
8.
Patrono D, Cussa D, Sciannameo V, Montanari E, Panconesi R, Berchialla P, et al.
Am J Transplant
. 2022 Feb;
22(5):1382-1395.
PMID: 35150050
Prompted by the utilization of extended criteria donors, dual hypothermic oxygenated machine perfusion (D-HOPE) was introduced in liver transplantation to improve preservation. When donors after neurological determination of death (DBD)...
9.
Patrono D, Roggio D, Mazzeo A, Catalano G, Mazza E, Rizza G, et al.
Artif Organs
. 2021 Sep;
46(2):281-295.
PMID: 34516020
Background: While growing evidence supports the use of hypothermic oxygenated machine perfusion (HOPE) in liver transplantation, its effects on liver metabolism are still incompletely understood. Methods: To assess liver metabolism...
10.
Patrono D, Sofia S, Caropreso P, Catalano G, Rizza G, Mazza E, et al.
Ann Surg
. 2020 Oct;
274(6):e686-e688.
PMID: 33064396
No abstract available.